Encompass Health (NYSE:EHC) Price Target Raised to $125.00 at Royal Bank of Canada

Encompass Health (NYSE:EHC) had its price target increased by analysts at Royal Bank of Canada from $110.00 to $125.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective would suggest a potential upside of 9.47% from the stock’s current price.

Other equities research analysts have also recently issued reports about the stock. Barclays raised their target price on shares of Encompass Health from $118.00 to $129.00 and gave the stock an “overweight” rating in a research report on Friday. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Friday. KeyCorp increased their price objective on Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a report on Friday. Truist Financial reiterated a “buy” rating and issued a $135.00 price target (up from $116.00) on shares of Encompass Health in a research note on Monday. Finally, William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Nine equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Encompass Health has a consensus rating of “Buy” and an average price target of $118.00.

Encompass Health Trading Up 0.7 %

EHC stock traded up $0.82 during trading on Monday, hitting $114.19. 367,945 shares of the company traded hands, compared to its average volume of 674,569. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company has a 50-day moving average of $100.08 and a 200-day moving average of $98.57. The firm has a market capitalization of $11.50 billion, a PE ratio of 25.66, a P/E/G ratio of 2.31 and a beta of 0.87. Encompass Health has a 1 year low of $82.38 and a 1 year high of $115.48.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Analysts predict that Encompass Health will post 4.8 earnings per share for the current fiscal year.

Insider Activity

In other news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.10% of the company’s stock.

Hedge Funds Weigh In On Encompass Health

Several hedge funds and other institutional investors have recently modified their holdings of the company. Morse Asset Management Inc bought a new stake in shares of Encompass Health during the 3rd quarter valued at about $68,000. Tidal Investments LLC raised its position in Encompass Health by 5.7% in the third quarter. Tidal Investments LLC now owns 3,509 shares of the company’s stock worth $339,000 after acquiring an additional 188 shares during the period. Synovus Financial Corp grew its position in shares of Encompass Health by 92.9% during the 3rd quarter. Synovus Financial Corp now owns 16,057 shares of the company’s stock valued at $1,552,000 after acquiring an additional 7,733 shares during the period. Franklin Resources Inc. raised its holdings in Encompass Health by 22.0% in the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock worth $67,412,000 after purchasing an additional 126,000 shares during the period. Finally, GAMMA Investing LLC raised its holdings in Encompass Health by 22.1% in the 4th quarter. GAMMA Investing LLC now owns 1,947 shares of the company’s stock worth $180,000 after purchasing an additional 352 shares during the period. 97.25% of the stock is owned by institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.